betulinic acid has been researched along with Granulocytic Leukemia, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fang, Q; Lu, T; Ma, D; Wang, J; Wei, D; Xiong, J; Yu, K | 1 |
Buffon, A; da Silva, GNS; de Oliveira, CB; Gnoatto, SCB; Pilger, DA; Trivella, DBB; Vieira, BD; Waechter, F; Willig, JB; Zimmer, AR | 1 |
Badrinath, Y; Joshi, DS; Mishra, KP; Narkar, AA; Raghuvar Gopal, DV | 1 |
3 other study(ies) available for betulinic acid and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase-independent, imatinib-resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation.
Topics: Adult; Apoptosis; Betulinic Acid; Bone Marrow Cells; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Histone Deacetylases; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pentacyclic Triterpenes; Signal Transduction; Triterpenes; Ubiquitination; Young Adult | 2020 |
Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia.
Topics: Antineoplastic Agents; Betulinic Acid; Drug Design; Drug Screening Assays, Antitumor; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pentacyclic Triterpenes; Spectrum Analysis; Structure-Activity Relationship; Triterpenes | 2017 |
Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl.
Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Drug Evaluation, Preclinical; Electrophoresis, Agar Gel; Fluorescein-5-isothiocyanate; Fusion Proteins, bcr-abl; Gene Expression; Humans; Inhibitory Concentration 50; Intracellular Membranes; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potentials; Mitochondria; Pentacyclic Triterpenes; Triterpenes | 2005 |